Tested Applications
| Positive WB detected in | HepG2 cells, Sp2/0 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
13311-1-AP targets TRAM2 in WB, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag4144 Product name: Recombinant human TRAM2 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 300-370 aa of BC028121 Sequence: CAAQAWLMWRFIHSQLRHWREYWNEQSAKRRVPATPRLPARLIKRESGYHENGVVKAENGTSPRTKKLKSP Predict reactive species |
| Full Name | translocation associated membrane protein 2 |
| Calculated Molecular Weight | 370 aa, 43 kDa |
| Observed Molecular Weight | 43 kDa, 66 kDa |
| GenBank Accession Number | BC028121 |
| Gene Symbol | TRAM2 |
| Gene ID (NCBI) | 9697 |
| RRID | AB_10598476 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q15035 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| WB protocol for TRAM2 antibody 13311-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The TRAM2 Polyclonal antibody (Cat# 13311-1-AP) has 1 citation. It was used in a study published in Frontiers in Immunology (2022), which performed a comprehensive analysis of glycolysis and cholesterol synthesis-related gene signatures for predicting prognosis and immune landscape in osteosarcoma. The research fields associated with this citation include cancer biology (osteosarcoma), metabolic pathways (glycolysis and cholesterol synthesis), and immunology (immune landscape).
| Species | Application | Title |
|---|---|---|
Front Immunol Comprehensive analysis of a glycolysis and cholesterol synthesis-related genes signature for predicting prognosis and immune landscape in osteosarcoma
|





